Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Therapeutics”

1,490 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,490 results

Post-approval studies (Phase 4)Study completedNCT02417142
What this trial is testing

Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Massachusetts, Worcester 70
Not applicableStudy completedNCT00018642
What this trial is testing

Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
US Department of Veterans Affairs
Not applicableNot Yet RecruitingNCT07506070
What this trial is testing

Implementing Action-Based Cognitive Remediation for Transdiagnostic Cognitive Difficulties in a Tertiary Mental Health Hospital

Who this might be right for
Psychiatric DisordersDepression - Major Depressive DisorderSchizophrenia and Other Psychotic Disorders+4 more
The Royal Ottawa Mental Health Centre 160
Testing effectiveness (Phase 2)Study completedNCT03751280
What this trial is testing

Study of Efficacy of PEAR-004 in Schizophrenia

Who this might be right for
Schizophrenia
Novartis Pharmaceuticals 112
Post-approval studies (Phase 4)Study completedNCT00191555
What this trial is testing

Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment

Who this might be right for
Schizophrenia
Eli Lilly and Company 360
Not applicableStudy completedNCT02531243
What this trial is testing

Computer-Aided Learning for Managing Stress

Who this might be right for
Psychosis
Beth Israel Deaconess Medical Center 25
Not applicableStudy completedNCT04902066
What this trial is testing

Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".

Who this might be right for
Paranoid SchizophreniaSchizophrenia and Related DisordersSchizophrenia Prodromal+8 more
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 259
Not applicableStudy completedNCT02600741
What this trial is testing

Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

Who this might be right for
Schizophrenia
Janssen Scientific Affairs, LLC 296
Large-scale testing (Phase 3)Study completedNCT03503318
What this trial is testing

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

Who this might be right for
Schizophrenia
Teva Branded Pharmaceutical Products R&D, Inc. 544
Not applicableStudy completedNCT01391390
What this trial is testing

Melatonin Treatment for Tardive Dyskinesia in Schizophrenia

Who this might be right for
Tardive Dyskinesia
Beijing HuiLongGuan Hospital 120
Not applicableStudy completedNCT00996242
What this trial is testing

An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Göteborg University 10
Large-scale testing (Phase 3)Study completedNCT00366171
What this trial is testing

Open Label Extension Study of Bifeprunox

Who this might be right for
Schizophrenia
Wyeth is now a wholly owned subsidiary of Pfizer 120
Testing effectiveness (Phase 2)Study completedNCT01548612
What this trial is testing

Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia

Who this might be right for
Schizophrenia
University of Sao Paulo 20
Large-scale testing (Phase 3)Study completedNCT02013609
What this trial is testing

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

Who this might be right for
MDD
Otsuka Pharmaceutical Development & Commercialization, Inc. 48
Post-approval studies (Phase 4)Study completedNCT00239109
What this trial is testing

Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 112
Post-approval studies (Phase 4)Study completedNCT00848432
What this trial is testing

Risperidone Maintenance Treatment in Schizophrenia

Who this might be right for
Schizophrenia
Capital Medical University 404
Large-scale testing (Phase 3)Study completedNCT00237809
What this trial is testing

D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Yale University 104
Large-scale testing (Phase 3)WithdrawnNCT00000372
What this trial is testing

Glycine and D-Cycloserine in Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital
Post-approval studies (Phase 4)Study completedNCT01105481
What this trial is testing

Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients

Who this might be right for
Treatment-resistant Schizophrenia
National Health Research Institutes, Taiwan 273
Large-scale testing (Phase 3)Study completedNCT00401973
What this trial is testing

Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine

Who this might be right for
SchizophreniaSchizoaffective Disorders
Eli Lilly and Company 199
Next Page